Lehman & Derafelo Financial Resources’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $10.9M | Sell |
211,824
-1,115
| -0.5% | -$53.5K | 3.22% | 6 |
|
|
2022
Q3 | $9.32M | Sell |
212,939
-3,735
| -2% | -$181K | 2.94% | 8 |
|
|
2022
Q2 | $11.4M | Buy |
216,674
+1,289
| +0.6% | +$65.7K | 3.51% | 6 |
|
|
2022
Q1 | $11.2M | Buy |
215,385
+625
| +0.3% | +$32.4K | 3.1% | 8 |
|
|
2021
Q4 | $12.7M | Sell |
214,760
-1,308
| -0.6% | -$64.8K | 3.83% | 5 |
|
|
2021
Q3 | $9.29M | Sell |
216,068
-2,360
| -1% | -$105K | 3.02% | 7 |
|
|
2021
Q2 | $8.55M | Buy |
218,428
+5,917
| +3% | +$230K | 2.34% | 9 |
|
|
2021
Q1 | $7.7M | Buy |
212,511
+7,354
| +4% | +$261K | 2.16% | 9 |
|
|
2020
Q4 | $7.55M | Buy |
205,157
+1,695
| +0.8% | +$62.2K | 2.26% | 9 |
|
|
2020
Q3 | $7.47M | Buy |
203,462
+14
| +0% | +$517 | 2.38% | 7 |
|
|
2020
Q2 | $6.65M | Buy |
203,448
+845
| +0.4% | +$30.3K | 2.32% | 9 |
|
|
2020
Q1 | $6.61M | Sell |
202,603
-616
| -0.3% | -$22.1K | 2.75% | 7 |
|
|
2019
Q4 | $7.96M | Buy |
203,219
+316
| +0.2% | +$11.9K | 2.86% | 8 |
|
|
2019
Q3 | $7.29M | Buy |
202,903
+5,718
| +3% | +$219K | 2.79% | 7 |
|
|
2019
Q2 | $8.66M | Buy |
197,185
+2,284
| +1% | +$95.6K | 3.53% | 6 |
|
|
2019
Q1 | $8.28M | Sell |
194,901
-1,286
| -0.7% | -$54.3K | 3.57% | 6 |
|
|
2018
Q4 | $8.56M | Sell |
196,187
-1,157
| -0.6% | -$50.6K | 4.26% | 5 |
|
|
2018
Q3 | $8.7M | Sell |
197,344
-3,286
| -2% | -$133K | 4.08% | 5 |
|
|
2018
Q2 | $7.28M | Sell |
200,630
-606
| -0.3% | -$21.8K | 3.67% | 6 |
|
|
2018
Q1 | $7.14M | Sell |
201,236
-5,557
| -3% | -$201K | 3.66% | 6 |
|
|
2017
Q4 | $7.49M | Sell |
206,793
-4,039
| -2% | -$145K | 3.89% | 6 |
|
|
2017
Q3 | $7.53M | Buy |
210,832
+2,311
| +1% | +$78.3K | 3.83% | 5 |
|
|
2017
Q2 | $7.01M | Buy |
208,521
+1,737
| +0.8% | +$57.7K | 3.95% | 5 |
|
|
2017
Q1 | $7.07M | Buy |
206,784
+1,813
| +0.9% | +$60.2K | 3.91% | 6 |
|
|
2016
Q4 | $6.66M | Buy |
204,971
+7,709
| +4% | +$248K | 3.79% | 7 |
|
|
2016
Q3 | $6.68M | Buy |
197,262
+2,307
| +1% | +$81.3K | 3.86% | 5 |
|
|
2016
Q2 | $6.86M | Buy |
194,955
+163
| +0.1% | +$5.48K | 3.45% | 5 |
|
|
2016
Q1 | $5.77M | Buy |
194,792
+933
| +0.5% | +$28.1K | 3.08% | 7 |
|
|
2015
Q4 | $6.26M | Buy |
193,859
+809
| +0.4% | +$26.8K | 3.37% | 5 |
|
|
2015
Q3 | $6.06M | Buy |
193,050
+1,270
| +0.7% | +$42.9K | 3.09% | 5 |
|
|
2015
Q2 | $6.43M | Sell |
191,780
-2,144
| -1% | -$73.6K | 3.11% | 5 |
|
|
2015
Q1 | $6.75M | Buy |
193,924
+205
| +0.1% | +$6.87K | 3.1% | 4 |
|
|
2014
Q4 | $6.03M | Buy |
193,719
+1,806
| +0.9% | +$54.6K | 2.96% | 7 |
|
|
2014
Q3 | $5.68M | Sell |
191,913
-97
| -0.1% | -$2.87K | 2.96% | 6 |
|
|
2014
Q2 | $5.7M | Buy |
192,010
+56,158
| +41% | +$1.69M | 2.72% | 5 |
|
|
2014
Q1 | $4.36M | Buy |
135,852
+2,003
| +1% | +$62.9K | 2.26% | 7 |
|
|
2013
Q4 | $4.1M | Sell |
133,849
-1,898
| -1% | -$58.2K | 2.53% | 7 |
|
|
2013
Q3 | $3.9M | Sell |
135,747
-497
| -0.4% | -$14.3K | 2.5% | 6 |
|
|
2013
Q2 | $3.82M | Hold |
136,244
| – | – | 2.58% | 6 |
|
Other funds holding PFE
Lehman & Derafelo Financial Resources's PFE Position: Q4 2022 in Review
Lehman & Derafelo Financial Resources reduced its Pfizer (PFE) stake by 0.52% in Q4 2022, selling an estimated $53.5K and leaving 211,824 shares worth $10.9M. The position accounts for 3.22% of the portfolio, ranked #6.
Lehman & Derafelo Financial Resources first reported a position in PFE in Q2 2013 and has held it in 39 quarters since. The position peaked at $12.7M in Q4 2021. 3,263 funds tracked by Wall St. Rank hold PFE as of Q4 2022.
- Lehman & Derafelo Financial Resources held 211,824 shares of Pfizer worth $10.9M as of Q4 2022.
- Lehman & Derafelo Financial Resources sold 1,115 Pfizer shares in Q4 2022, an estimated $53.5K.
- Pfizer made up 3.22% of Lehman & Derafelo Financial Resources's portfolio in Q4 2022, its #6 holding.
- Lehman & Derafelo Financial Resources first reported a position in Pfizer in Q2 2013 and has held it in 39 quarters since.
- Lehman & Derafelo Financial Resources's Pfizer position peaked at $12.7M in Q4 2021.
- 3,263 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.
Based on Lehman & Derafelo Financial Resources's 13F filing for Q4 2022, filed 20 Jan 2023.